The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of pembrolizumab-based therapy in previously treated extrapulmonary poorly differentiated neuroendocrine carcinomas: Results of Part A (pembrolizumab alone).
 
Claire Mulvey
No Relationships to Disclose
 
Nitya Prabhakar Raj
Research Funding - Novartis (Inst)
 
Jennifer A. Chan
Stock and Other Ownership Interests - Merck
Honoraria - Ipsen
Consulting or Advisory Role - Advanced Accelerator Applications; Exelixis; Ipsen; Novartis
Research Funding - Lilly (Inst); Sanofi (Inst)
 
Rahul Raj Aggarwal
Consulting or Advisory Role - AstraZeneca
Research Funding - Abbvie; Cancer Targeted Technology; Gilead Sciences; Janssen; Merck; Novartis; Xynomic Pharma; Zenith Epigenetics
 
Pelin Cinar
Research Funding - Newlink Genetics
 
Thomas A Hope
Consulting or Advisory Role - Ipsen
Research Funding - GE Healthcare (Inst)
 
Kanti Kolli
Stock and Other Ownership Interests - Adient Medical
Consulting or Advisory Role - Penumbra; Surefire Medical
 
Li Zhang
Consulting or Advisory Role - Dendreon; Fortis; Unity Biotechnology
Travel, Accommodations, Expenses - Dendreon
 
Susan Calabrese
No Relationships to Disclose
 
Jennifer Ann Grabowsky
No Relationships to Disclose
 
Lila Modarresi
No Relationships to Disclose
 
Virginia Kelly
No Relationships to Disclose
 
Danielle Stonely
No Relationships to Disclose
 
Pamela N. Munster
Stock and Other Ownership Interests - OncoSec (I)
Honoraria - Amgen (I); Prometheus (I); Threshold Pharmaceuticals
Consulting or Advisory Role - HUYA Bioscience International
Research Funding - Andes Biotechnologies (Inst); Biomarin (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Immune Design (Inst); Intellikine (Inst); Merck (Inst); Merrimack (Inst); Nektar (Inst); Novartis (Inst); OncoMed (Inst); Onconova Therapeutics (Inst); oncosec (Inst); Pfizer (Inst); Piramal Life Science (Inst); Plexxikon (Inst); Sanofi (Inst)
 
Diane Lauren Reidy
Honoraria - Novartis
Consulting or Advisory Role - Ipsen; Novartis; Pfizer
Research Funding - Novartis
 
Lawrence Fong
Consulting or Advisory Role - Atreca; IDEAYA Biosciences; MIODx
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Merck (Inst); Roche/Genentech (Inst)
 
Emily K. Bergsland
Stock and Other Ownership Interests - More Health (I)
Consulting or Advisory Role - More Health; more health (I); Novartis
Research Funding - lexicon (Inst); Merck; Novartis (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate